HCW Biologics is a clinical stage biopharmaceutical company advancing a pipeline of potentially transformative fusion immunotherapeutic product candidates for the treatment of diseases promoted by chronic inflammation. We have begun commercialization of certain commercial-ready proprietary molecules for use as reagents in the production of immunotherapeutics for the treatment of infectious diseases and cancer.